STAMP: A team accelerating better treatments for Sjögren’s disease
Sjögren’s Team for Accelerating Medicines Partnership (STAMP)
This project brings together people with Sjögren’s disease to build a detailed patient resource that speeds up discovery of better tests and treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11302628 on NIH RePORTER |
What this research studies
If you join, researchers will collect detailed medical histories and biosamples (like blood and saliva) and link new volunteers with existing patient groups to form a large, well-characterized cohort. You may have clinical exams, laboratory tests, and imaging, and researchers will store samples for future studies. Scientists will study genetics, immune cells, and molecular markers to understand why glands and other organs are affected. The team will follow participants over time to track symptoms and outcomes to help design better clinical trials.
Who could benefit from this research
Good fit: People diagnosed with Sjögren’s disease, including those with dry eyes/mouth or extraglandular symptoms, who can provide clinical information and biosamples are ideal candidates.
Not a fit: People without Sjögren’s disease or those unable to provide samples or attend required visits are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could lead to clearer diagnoses, identify new treatment targets, and speed up development of more effective therapies for Sjögren’s patients.
How similar studies have performed: Building large, deeply characterized patient cohorts has helped advance treatments in other autoimmune diseases, and applying that approach to Sjögren’s is promising though relatively new.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Shiboski, Caroline Helene — University of California, San Francisco
- Study coordinator: Shiboski, Caroline Helene
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.